Literature DB >> 22915801

Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.

Gregory J Raymond1, Brent Race, Jason R Hollister, Danielle K Offerdahl, Roger A Moore, Ravindra Kodali, Lynne D Raymond, Andrew G Hughson, Rebecca Rosenke, Dan Long, David W Dorward, Gerald S Baron.   

Abstract

Mammalian prions are thought to consist of misfolded aggregates (protease-resistant isoform of the prion protein [PrP(res)]) of the cellular prion protein (PrP(C)). Transmissible spongiform encephalopathy (TSE) can be induced in animals inoculated with recombinant PrP (rPrP) amyloid fibrils lacking mammalian posttranslational modifications, but this induction is inefficient in hamsters or transgenic mice overexpressing glycosylphosphatidylinositol (GPI)-anchored PrP(C). Here we show that TSE can be initiated by inoculation of misfolded rPrP into mice that express wild-type (wt) levels of PrP(C) and that synthetic prion strain propagation and selection can be affected by GPI anchoring of the host's PrP(C). To create prions de novo, we fibrillized mouse rPrP in the absence of molecular cofactors, generating fibrils with a PrP(res)-like protease-resistant banding profile. These fibrils induced the formation of PrP(res) deposits in transgenic mice coexpressing wt and GPI-anchorless PrP(C) (wt/GPI(-)) at a combined level comparable to that of PrP(C) expression in wt mice. Secondary passage into mice expressing wt, GPI(-), or wt plus GPI(-) PrP(C) induced TSE disease with novel clinical, histopathological, and biochemical phenotypes. Contrary to laboratory-adapted mouse scrapie strains, the synthetic prion agents exhibited a preference for conversion of GPI(-) PrP(C) and, in one case, caused disease only in GPI(-) mice. Our data show that novel TSE agents can be generated de novo solely from purified mouse rPrP after amplification in mice coexpressing normal levels of wt and anchorless PrP(C). These observations provide insight into the minimal elements required to create prions in vitro and suggest that the PrP(C) GPI anchor can modulate the propagation of synthetic TSE strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915801      PMCID: PMC3486332          DOI: 10.1128/JVI.01353-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  Cyclic amplification of protein misfolding: application to prion-related disorders and beyond.

Authors:  Claudio Soto; Gabriela P Saborio; Laurence Anderes
Journal:  Trends Neurosci       Date:  2002-08       Impact factor: 13.837

2.  Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation.

Authors:  Chan-Lan Kim; Ayako Karino; Naotaka Ishiguro; Morikazu Shinagawa; Motoyoshi Sato; Motohiro Horiuchi
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

3.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

4.  Self-replication and scrapie.

Authors:  J S Griffith
Journal:  Nature       Date:  1967-09-02       Impact factor: 49.962

5.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain.

Authors:  B Chesebro; R Race; K Wehrly; J Nishio; M Bloom; D Lechner; S Bergstrom; K Robbins; L Mayer; J M Keith
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

7.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene.

Authors:  K Basler; B Oesch; M Scott; D Westaway; M Wälchli; D F Groth; M P McKinley; S B Prusiner; C Weissmann
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

8.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

9.  Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification.

Authors:  Paula Saá; Joaquín Castilla; Claudio Soto
Journal:  J Biol Chem       Date:  2006-09-18       Impact factor: 5.157

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  25 in total

1.  Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.

Authors:  Brent Race; Katie Phillips; Kimberly Meade-White; James Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  The many shades of prion strain adaptation.

Authors:  Ilia V Baskakov
Journal:  Prion       Date:  2014-02-11       Impact factor: 3.931

3.  Amyloid fibrils from the N-terminal prion protein fragment are infectious.

Authors:  Jin-Kyu Choi; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Pierluigi Gambetti; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

4.  PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Authors:  Allison Kraus; Gregory J Raymond; Brent Race; Katrina J Campbell; Andrew G Hughson; Kelsie J Anson; Lynne D Raymond; Byron Caughey
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

5.  PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains.

Authors:  Eri Saijo; Andrew G Hughson; Gregory J Raymond; Akio Suzuki; Motohiro Horiuchi; Byron Caughey
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

6.  Dissociation of recombinant prion autocatalysis from infectivity.

Authors:  Geoffrey P Noble; Surachai Supattapone
Journal:  Prion       Date:  2015       Impact factor: 3.931

7.  Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.

Authors:  M Jeffrey; G McGovern; N Makarava; L González; Y-S Kim; R G Rohwer; I V Baskakov
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

8.  Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.

Authors:  Kazunori Sano; Ryuichiro Atarashi; Daisuke Ishibashi; Takehiro Nakagaki; Katsuya Satoh; Noriyuki Nishida
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

9.  Infectious prions and proteinopathies.

Authors:  Rona M Barron
Journal:  Prion       Date:  2017-01-02       Impact factor: 3.931

10.  Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.

Authors:  Pedro Piccardo; Declan King; Glenn Telling; Jean C Manson; Rona M Barron
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.